Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Exploring the Impact of Trauma on Cellular Aging
Published on: March 22, 2024
The Relationship between Telomere Length and Cancer Mortality: Data from the 1999-2002 National Healthy and Nutrition
1YingQing Feng, Department of Cardiology, Guangdong Cardiovascular Institute, Hypertension Research Laboratory, Guangdong Provincial People's Hospital, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, 510080 Guangzhou, China, 651792209@qq.com.
Objectives:
The association between telomeres length (TL) and cancer mortality is uncertain. We tested the hypotheses that long TL are associated with reduced cancer mortality.
Design:
Prospective cohort study.
Setting:
the National Health and Nutrition Survey (NHANES, 1999-2002).
Participants:
The analytic sample included adults (n = 7183) who had TL measurements.
Measurements:
DNA was obtained via blood samples. Telomere length was assessed using the quantitative polymerase chain reaction method.
Results:
During follow-up (0.08-12.7 person-years, median = 9.5 years), we observed 195 participants had cancer as causes of death. TL was negatively corelated with age, body mass index (BMI), systolic blood pressure (SBP), C-reactive protein (CRP), race, diabetes, hypertension, cardiovascular diseases (CVD) and cancer mortality, conversely, positively corelated with alcohol use, but not related to diastolic blood pressure (DBP) and smoking. Kaplan-Meier analysis revealed that TL was significantly associated with cancer mortality (log-rank, P <0.001).
Conclusions:
Our study expands upon previous evidence of a relationship between TL and cancer mortality. TL may be a useful tool for evaluating risk of cancer mortality in American adults.
Related Concept Videos
Replicative Cell Senescence
Cancer Survival Analysis
Longitudinal Research
Telomeres and Telomerase
Telomeres and Telomerase
Cancer Prevention
Some...

